scholarly article | Q13442814 |
P50 | author | Stuart T. Nichol | Q60415973 |
P2093 | author name string | Brian H Bird | |
Ayan K Chakrabarti | |||
César G Albariño | |||
Bobbie Rae Erickson | |||
Kimberly A Dodd | |||
P2860 | cites work | Mfold web server for nucleic acid folding and hybridization prediction | Q24498105 |
Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus | Q24541217 | ||
Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest | Q24644904 | ||
Mutational analysis of the lassa virus promoter | Q24673622 | ||
Envelope exchange for the generation of live-attenuated arenavirus vaccines | Q27320211 | ||
High diversity and ancient common ancestry of lymphocytic choriomeningitis virus | Q28730699 | ||
Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever | Q34148663 | ||
Nucleotide sequence conservation at the 3' termini of the virion RNA species of New World and Old World arenaviruses. | Q34253643 | ||
Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease | Q34485294 | ||
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA | Q34574914 | ||
Reverse genetics approaches to combat pathogenic arenaviruses | Q34596958 | ||
Lassa fever. Effective therapy with ribavirin | Q34694588 | ||
Lassa virus | Q35919691 | ||
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice | Q36905074 | ||
Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing | Q39868272 | ||
Rescue of the prototypic Arenavirus LCMV entirely from plasmid | Q40316804 | ||
Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes | Q40355385 | ||
Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers | Q40391705 | ||
Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. | Q40453546 | ||
Efficient bunyavirus rescue from cloned cDNA. | Q40487364 | ||
Lassa fever: epidemiology, therapy and vaccine development. | Q40788225 | ||
Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone | Q40903379 | ||
Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domains | Q41592314 | ||
Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation | Q42066120 | ||
The 3' end termini of the Tacaribe arenavirus subgenomic RNAs | Q43756937 | ||
Lassa fever | Q78037746 | ||
A single stem-loop structure in Tacaribe arenavirus intergenic region is essential for transcription termination but is not required for a correct initiation of transcription and replication | Q79381623 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Lassa virus | Q1806636 |
P304 | page(s) | 4020-4024 | |
P577 | publication date | 2011-02-09 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence | |
P478 | volume | 85 |
Q26823627 | Advanced vaccine candidates for Lassa fever |
Q38608502 | Arenavirus Quasispecies and Their Biological Implications |
Q37006773 | Arenavirus reverse genetics for vaccine development |
Q34274569 | Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses |
Q64097889 | Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors |
Q38502997 | Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis |
Q94954969 | Lassa Virus Genetics |
Q40056797 | Lassa Virus Reverse Genetics |
Q64073768 | Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model |
Q38959283 | Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages |
Q38818648 | Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines. |
Q37934045 | Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses |
Q26742028 | Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses |
Q37543755 | Reverse Genetics Approaches to Control Arenavirus. |
Q36276510 | Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth |
Q27305359 | Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus |
Q38069359 | Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever |
Q56913187 | The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model |
Q38748634 | The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain |
Q36588064 | The search for animal models for Lassa fever vaccine development |
Q56576756 | Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model |
Q33723534 | VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever |
Q55385702 | Xapuri virus, a novel mammarenavirus: natural reassortment and increased diversity between New World viruses. |